NDC 0597-0390 – Trijardy XR
Empagliflozin 25 mg/1; Linagliptin 5 mg/1; Metformin Hydrochloride 1000 mg/1 · Tablet, Extended Release · Oral
Product NDC0597-0390
Product details
- Brand name
- Trijardy XR
- Generic name
- Empagliflozin, linagliptin, metformin hydrochloride
- Labeler
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- NDA · NDA212614
- Marketed since
- April 23, 2020
- Listing expires
- December 31, 2027
- Pharmacologic class
- Biguanide; Dipeptidyl Peptidase 4 Inhibitor; Sodium-Glucose Cotransporter 2 Inhibitor
Active ingredients
- Empagliflozin 25 mg/1
- Linagliptin 5 mg/1
- Metformin Hydrochloride 1000 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0597-0390-13 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0390-13) | Apr 23, 2020 |
| 0597-0390-71 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0390-71) | Apr 23, 2020 |
Other Trijardy XR products
- 0597-0380 Empagliflozin 10 mg/1; Linagliptin 5 mg/1; Metformin Hydrochloride… · Tablet, Extended Release · Boehringer Ingelheim Pharmaceuticals, Inc.
- 0597-0385 Empagliflozin 12.5 mg/1; Linagliptin 2.5 mg/1; Metformin… · Tablet, Extended Release · Boehringer Ingelheim Pharmaceuticals, Inc.
- 0597-0395 Empagliflozin 5 mg/1; Linagliptin 2.5 mg/1; Metformin Hydrochloride… · Tablet, Extended Release · Boehringer Ingelheim Pharmaceuticals, Inc.